News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arrowhead Research Corporation (ARWR) Announces Inducement Grants Under NASDAQ Rule 5635(c)(4)


10/28/2013 10:42:48 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced it awarded "inducement" options to two new employees under Rule 5635(c)(4) of the NASDAQ Marketplace Rules as an inducement for entering into employment with the Company. The options entitle the employees to purchase, outside of the Company's stockholder approved equity incentive plans, an aggregate of up to 105,000 shares of the Company's common stock at an exercise price per share of $7.98, the last reported closing price of the Company's common stock on the date of grants. The options vest and become exercisable over a period of four years from the date of grant.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES